Clinical Trial: A Long-term Observational Study in Participants Who Have Received PBGENE-HBV

U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254208) titled 'A Long-term Observational Study in Participants Who Have Received PBGENE-HBV' on Nov. 19.

Brief Summary: Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.

Study Start Date: Dec. 25

Study Type: OBSERVATIONAL

Condition: Chronic HBV Infection

Intervention: BIOLOGICAL: PBGENE-HBV

PBGENE-HBV is the investigational product administered in the parent study. This LTFU study is non-interventional; no investigational product given.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Precision BioSciences, Inc.

Disclaimer: Curated by HT Syndication....